Pfizer (PFE)
(Delayed Data from NYSE)
$29.09 USD
+0.12 (0.41%)
Updated Sep 27, 2024 04:02 PM ET
After-Market: $29.09 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth D Momentum D VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$29.09 USD
+0.12 (0.41%)
Updated Sep 27, 2024 04:02 PM ET
After-Market: $29.09 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
B Value F Growth D Momentum D VGM
Zacks News
ETFs to Consider on Pfizer's Vaccine Announcement
by Sejuti Banerjea
ETFs with exposure to Pfizer (PFE) are beginning to look good after the results of BNT162b2's Phase 3 trial.
Bet Big on Industrial Metal ETFs on Vaccine Optimism
by Sanghamitra Saha
Wall Street has been on a rallying mode in recent sessions on upbeat vaccine data and recovering global manufacturing activities.
Biggest ETF Winners from Coronavirus Vaccine News
by Neena Mishra
Promising vaccine results from Pfizer sent economically sensitive stocks soaring
Airline Stock Roundup: UAL & JBLU's Thanksgiving Plans, Azul's Traffic & More
by Maharathi Basu
JetBlue (JBLU) and United Airlines (UAL) intend to add flights to meet the anticipated demand swell during Thanksgiving. Meanwhile, Alaska Air's (ALK) CEO will call it quits next year.
The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna, AstraZeneca and Johnson & Johnson
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Moderna, AstraZeneca and Johnson & Johnson
Merck's (MRK) Keytruda Combo Meets Goal in Kidney Cancer Study
by Zacks Equity Research
Merck (MRK) and partner Eisai report positive top-line data from the phase III study evaluating Keytruda plus the latter's Lenvima for first-line treatment of patients with kidney cancer.
Stock Market News for Nov 11, 2020
by Zacks Equity Research
Wall Street had a mixed day on Tuesday with investor rushing to sell of tech stocks that had had dream run during the virus-induced lockdown, while they put money on sectors that took a beating during the pandemic.
Zacks Investment Ideas feature highlights: Pfizer, BioNTech, Peloton Interactive, AMC Entertainment and Etsy
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Pfizer, BioNTech, Peloton Interactive, AMC Entertainment and Etsy
Arrow Electronics, Clipper Realty, Pfizer, BioNTech and Moderna highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Arrow Electronics, Clipper Realty, Pfizer, BioNTech and Moderna highlighted as Zacks Bull and Bear of the Day
Vaccine Hopes Rise as Pharma Giants Inch Closer Toward Success
by Ritujay Ghosh
Stocks of Eli Lilly and Company (LLY), Pfizer, Inc. (PFE) and Moderna, Inc. (MRNA) have been in focus since the coronavirus outbreak as they have been the frontrunners in the vaccine race.
Vaccine News Lifts Energy Stocks Higher: 5 Stocks to Watch
by Zacks Equity Research
COVID-19 vaccine news aid energy stocks in moving higher making it judicious to watch out for prominent names like Oasis Petroleum (OASPQ) and PDC Energy (PDCE)
Vaccine Hopes Drive Demand for Value Stocks: 5 Picks
by Tirthankar Chakraborty
Value stocks are in favor now on vaccine hopes, which calls for investing in Red Robin Gourmet Burgers (RRGB), Matson (MATX), Malibu Boats (MBUU), Farmers National Banc (FMNB) and Northrim BanCorp (NRIM).
Leveraged ETF Areas That Gained the Most on Vaccine Hopes
by Sanghamitra Saha
Wall Street spiked on Nov 9 on news that a Pfizer and BioNTech vaccine candidate was more than 90% effective in avoiding COVID-19 in its clinical trial.
Vaccine Hopes & Divided Government: Sector ETFs to Win
by Sanghamitra Saha
News that a Pfizer and BioNTech vaccine candidate was more than 90% effective in avoiding COVID-19 in its clinical trial has instilled more optimism in the markets.
Payment Processing Stocks Gain on Coronavirus Vaccine News
by Zacks Equity Research
Upbeat COVID-19 vaccine news makes investors grow bullish on the payment processing stocks, leading to price rallies. As a result, travel will resume to aid cross-border payments for these companies.
Airline Stocks Gain on Vaccine News: Is the Rally Sustainable?
by Maharathi Basu
Shares of Delta (DAL), American Airlines (AAL) and United Airlines (UAL) appreciate in double-digits on Nov 9. Improvement in leisure-travel demand also bodes well for the airline stocks.
Reopening Stocks Gain on Vaccine Hopes
by Zacks Equity Research
Reopening Stocks Gain on Vaccine Hopes
Blue Chips & Tech Going Separate Directions: PFE, GOOGL, FB, LLY & More
by Mark Vickery
The last time we saw the Dow surge strongly ahead while the Nasdaq dipped into the red was back in 2000, when the tech bubble of the pre-Y2K market began to burst.
Stock Market News for Nov 10, 2020
by Zacks Equity Research
Wall Street ended mostly higher on Monday as investor confidence got a boost after data from late-stage clinical trials of coronavirus vaccine from two drugmakers showed positive results.
Pfizer COVID-19 Vaccine Data Raises Hopes for Industry, Economy
by Kinjel Shah
Pfizer (PFE)/BioNTech's (BNTX) COVID-19 vaccine candidate proves to be 90% effective in phase III.
The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Mohawk Industries, Electrolux and Jabil
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Pfizer, BioNTech, Mohawk Industries, Electrolux and Jabil
The Zacks Analyst Blog Highlights: NVIDIA, Netflix, Starbucks, Pfizer, Estee Lauder and Stryker
by Zacks Equity Research
The Zacks Analyst Blog Highlights: NVIDIA, Netflix, Starbucks, Pfizer, Estee Lauder and Stryker
Zacks Investment Ideas feature highlights: Pfizer, BioNTech, Delta Air Lines, Disney and Peloton Interactive
by Zacks Equity Research
Zacks Investment Ideas feature highlights: Pfizer, BioNTech, Delta Air Lines, Disney and Peloton Interactive
Here's Why JPM, BAC, C, WFC and Other Bank Stocks are Soaring
by Swayta Shah
The coronavirus vaccine-related news by Pfizer (PFE) will have positive financial implications on banks. So, almost all banks - big/small like JPMorgan (JPM), BofA (BAC), Citi (C), Wells Fargo (WFC), Webster (WBS) and Prosperity (PB) - have been rallying.
Pfizer (PFE) in Focus: Stock Moves 7.7% Higher
by Zacks Equity Research
Pfizer (PFE) saw a big move last session, as its shares jumped nearly 8% on the day, amid huge volumes.